Attorneys from the Khashayar Law Group, which is representing the family, did not immediately return a call for comment. The family argues in the suit that Amin Noroozi's death was cut short by systematic medical failures at John Muir Health. They called the hospital's actions gross negligence and said the life-threatening complications that led to Amin's death should have been anticipated and treated according to medical protocols.
"Dancing molecules," the promising new treatment for acute spinal cord injuries developed at Northwestern University, has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA).
